Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Fatty Acid Synthase ELISA Kit (AC2721)
Cat.#: ASET-1310
Specifications
Description Human Fatty Acid Synthase ELISA Kit allows for the in vitro quantitative determination of human Fatty Acid Synthase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1829 Human Granulin ELISA Kit (AC3240) Quantitative inquiry ASET-1317 Rabbit PEDF ELISA Kit (AC2728) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-2511 Rat Neuropeptide S ELISA Kit (AC3922) Quantitative inquiry ASET-2515 Human CALCB ELISA Kit (AC3926) Quantitative inquiry ASET-1839 Human Chordin ELISA Kit (AC3250) Quantitative inquiry ASET-2527 Human Chromogranin A ELISA Kit (AC3938) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-1198 Rat CD147 ELISA Kit (AC2609) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket